Loading data
UPBNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 2.85 m USD | 2.37 m USD | 2.38 m USD |
| Research and development expense | 136.81 m USD | 62.97 m USD | 31.8 m USD |
| Operating profit | -160.36 m USD | -77.76 m USD | -40.11 m USD |
| Income tax expense | 0 USD | 0 USD | — |
| Net income (reported basis) | -143.44 m USD | -62.8 m USD | -20.5 m USD |
| Net income attributable to common shareholders | -143.44 m USD | -76.4 m USD | -38.26 m USD |
| Basic earnings per share | -2.66 USD/share | -5.58 USD/share | -12.95 USD/share |
| Diluted earnings per share | -2.66 USD/share | -5.58 USD/share | -12.95 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.